McKesson Reaches New 52-Week High (MCK)

NEW YORK ( TheStreet) -- McKesson (NYSE: MCK) hit a new 52-week high Friday as it is currently trading at $87.68, above its previous 52-week high of $87.67 with 358,817 shares traded as of 9:40 a.m. ET. Average volume has been 1.6 million shares over the past 30 days.

McKesson has a market cap of $18.8 billion and is part of the services sector and wholesale industry. Shares are up 12.3% year to date as of the close of trading on Thursday.

McKesson Corporation delivers medicines, pharmaceutical supplies, information, and care management products and services for the healthcare industry. The company has a P/E ratio of 20.4, above the average wholesale industry P/E ratio of 16.9 and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates McKesson as a buy. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, revenue growth, solid stock price performance, attractive valuation levels and impressive record of earnings per share growth. We feel these strengths outweigh the fact that the company shows weak operating cash flow. You can view the full McKesson Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.
null

If you liked this article you might like

House Committee: 2 Pharmacy Managers Sent 12.3 Million Opioid Doses to 1 Store

House Committee: 2 Pharmacy Managers Sent 12.3 Million Opioid Doses to 1 Store

Who Says There Are No Second Chances?

Who Says There Are No Second Chances?

Medical Supply Stocks Get Hit in Latest Example of the 'Amazon Effect'

Medical Supply Stocks Get Hit in Latest Example of the 'Amazon Effect'

Purdue Pharma to Downplay Opioids, Dump 50% of Sales Staff

Purdue Pharma to Downplay Opioids, Dump 50% of Sales Staff

Drug Supply Chain Stocks Dip After White House Recommendations on Drug Pricing

Drug Supply Chain Stocks Dip After White House Recommendations on Drug Pricing